XBiotech (XBIT) Gross Profit (2020 - 2022)
XBiotech (XBIT) posted quarterly Gross Profit of $284000.0 for Q4 2022, down 91.78% year-over-year from $3.5 million in Q4 2021, and down 80.61% quarter-over-quarter from $1.5 million in Q3 2022.
XBiotech (XBIT) Gross Profit (2020 - 2022) Analysis & Trends
XBiotech's Gross Profit history runs 3 years deep, the most recent figure standing at $284000.0 for Q4 2022.
- In Q4 2022, Gross Profit fell 91.78% year-over-year to $284000.0; the TTM figure through Sep 2023 stood at $284000.0 (down 95.65% YoY), while the FY2022 annual figure was $3.4 million, down 73.29% from the prior year.
- Gross Profit for Q4 2022 stood at $284000.0, down from $1.5 million in the prior quarter.
- The five-year high for Gross Profit was $3.5 million in Q4 2021, with the low at $284000.0 in Q4 2022.
- The 3-year median for Gross Profit is $2.4 million (2020), against an average of $2.1 million.
- The sharpest annual moves came in 2021 and 2022: Gross Profit surged 203.56% in 2021, then plunged 91.78% in 2022.
- XBiotech's Gross Profit stood at $3.0 million in 2020, then rose by 14.33% to $3.5 million in 2021, then slumped by 91.78% to $284000.0 in 2022.
- Business Quant data shows XBIT's Gross Profit at $284000.0 in Q4 2022, $1.5 million in Q3 2022, and $1.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 284,000.00 |
| Dec 31, 2022 | 284,000.00 |
| Sep 30, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 287,000.00 |
| Mar 31, 2022 | 287,000.00 |
| Dec 31, 2021 | 3.45 Mn |
| Dec 31, 2021 | 3.45 Mn |
| Sep 30, 2021 | 3.41 Mn |
| Sep 30, 2021 | 3.41 Mn |
| Jun 30, 2021 | 3.17 Mn |
| Jun 30, 2021 | 3.17 Mn |
| Mar 31, 2021 | 2.55 Mn |
| Mar 31, 2021 | 2.55 Mn |
| Dec 31, 2020 | 3.02 Mn |
| Dec 31, 2020 | 3.02 Mn |
| Sep 30, 2020 | 1.12 Mn |
| Sep 30, 2020 | 1.12 Mn |